874569-14-9

Basic information

• Product Name: [4-[[(2-methoxyphenyl)sulfonylamino]methyl]phenyl]boronic acid
• Synonyms: [4-[[(2-methoxyphenyl)sulfonylamino]methyl]phenyl]boronic acid
• CAS NO: 874569-14-9
• Molecular Weight: 321.162
• Mol File: 874569-14-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: [4-[[(2-methoxyphenyl)sulfonylamino]methyl]phenyl]boronic acid(CAS DataBase Reference)
• NIST Chemistry Reference: [4-[[(2-methoxyphenyl)sulfonylamino]methyl]phenyl]boronic acid(874569-14-9)
• EPA Substance Registry System: [4-[[(2-methoxyphenyl)sulfonylamino]methyl]phenyl]boronic acid(874569-14-9)

Safety Data

• Hazardous Substances Data: 874569-14-9(Hazardous Substances Data)

Upstream product

• 10130-87-7 o-Methoxybenzenesulfonyl chloride 

Downstream Products

• 874569-17-2 methyl 5-bromo-3-[4-({[(2-methoxyphenyl)sulfonyl]amino}methyl)phenyl]benzoate 
• 874569-21-8 methyl 2-methoxy-5-[4-({[(2-methoxyphenyl)sulfonyl]amino}methyl)phenyl]benzoate 
• 874569-23-0 phenylmethyl 5-[4-({[(2-methoxyphenyl)sulfonyl]amino}methyl)phenyl]-2-(phenylmethoxy)benzoate 
• 874569-19-4 6-[4-({[(2-methoxyphenyl)sulfonyl]amino}methyl)phenyl]-3-hydroisobenzofuran-1-one 

Relevant articles and documents

PYRAZOLO-PYRIMIDINES AS INHIBITORS OF BTK

This invention relates to novel compounds. The compounds of the invention are tyrosine kinase inhibitors. Specifically, the compounds of the invention are useful as inhibitors of Bruton's tyrosine kinase (BTK). The invention also contemplates the use of the compounds for treating conditions treatable by the inhibition of Bruton's tyrosine kinase, for example cancer, lymphoma, leukemia and immunological diseases.